The design of efficient ligands remains a key challenge in drug discovery. In the quest for lead-like ligands for the FK506-binding protein 51 (FKBP51), we designed two new classes of bicyclic sulfonamides to probe the contribution of conformational energy in these ligands. The [4.3.1] scaffold had consistently higher affinity compared to the [3.3.1] or monocyclic scaffolds, which could be attributed to better preorganization of two key recognition motifs. Surprisingly, the binding of the rigid [4.3.1] scaffold was enthalpy-driven and entropically disfavored compared to the flexible analogues. Cocrystal structures at atomic resolution revealed that the sulfonamide nitrogen in the bicyclic scaffolds can accept an unusual hydrogen bond from T...
Methyl groups can have profound effects in drug discovery but the underlying mechanisms are diverse ...
FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl is...
FKBP51 is well-known as a cochaperone of Hsp90 machinery and implicated in many human diseases inclu...
The design of efficient ligands remains a key challenge in drug discovery. In the quest for lead-lik...
The FK506-binding protein 51 (FKBP51) has emerged as an attractive new drug target for mood disorder...
The FK506-binding protein 51 (FKBP51) is a promising drug target for the treatment of stress-related...
The FK506-binding protein 51 (FKBP51) emerged as a key player in several diseases like stress-relate...
The FK506-binding protein 51 (FICBP51) is a promising drug target for the treatment of stress-relate...
Subtype selectivity represents a challenge in many drug discovery campaigns. A typical example is th...
FK506-binding proteins (FKBPs) have emerged as a promising drug target due to their role in various ...
Selective inhibition of FKBP51 has emerged as possible novel treatment for diseases like major depre...
The FK506-binding protein 51 (FKBP51) emerged as a key player in several diseases like stress-relate...
The FK506-binding. protein 51 (FKBP51) is a key regulator of stress hormone receptors and an establi...
In recent years the FK506-binding protein 51 (FKBP51) has emerged as a potential target for treating...
The FK506-binding protein 51 (FKBP51) is a key regulator of stress hormone receptors and an establis...
Methyl groups can have profound effects in drug discovery but the underlying mechanisms are diverse ...
FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl is...
FKBP51 is well-known as a cochaperone of Hsp90 machinery and implicated in many human diseases inclu...
The design of efficient ligands remains a key challenge in drug discovery. In the quest for lead-lik...
The FK506-binding protein 51 (FKBP51) has emerged as an attractive new drug target for mood disorder...
The FK506-binding protein 51 (FKBP51) is a promising drug target for the treatment of stress-related...
The FK506-binding protein 51 (FKBP51) emerged as a key player in several diseases like stress-relate...
The FK506-binding protein 51 (FICBP51) is a promising drug target for the treatment of stress-relate...
Subtype selectivity represents a challenge in many drug discovery campaigns. A typical example is th...
FK506-binding proteins (FKBPs) have emerged as a promising drug target due to their role in various ...
Selective inhibition of FKBP51 has emerged as possible novel treatment for diseases like major depre...
The FK506-binding protein 51 (FKBP51) emerged as a key player in several diseases like stress-relate...
The FK506-binding. protein 51 (FKBP51) is a key regulator of stress hormone receptors and an establi...
In recent years the FK506-binding protein 51 (FKBP51) has emerged as a potential target for treating...
The FK506-binding protein 51 (FKBP51) is a key regulator of stress hormone receptors and an establis...
Methyl groups can have profound effects in drug discovery but the underlying mechanisms are diverse ...
FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl is...
FKBP51 is well-known as a cochaperone of Hsp90 machinery and implicated in many human diseases inclu...